The U.S., where COVID-19 cases are still soaring, is expected to approve the Pfizer-BioNTech vaccine this week. As Jackson Proskow explains, now come the hurdles of distributing the shot, and convincing people to get it.
- CDC official ordered to delete email suggesting U.S. political interference: probe
- U.S. faces final step in race to give Pfizer’s coronavirus vaccine the green light
- Coronavirus restrictions in U.S. spark escalating protests, threats against officials